Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)

Early Intestinal Ultrasound in Predicting Treatment Response to Filgotinib in Ulcerative Colitis

NCT05653791 ·Status: UNKNOWN

Study to Evaluate the Efficacy and Safety of Filgotinib in the Treatment of Perianal Fistulizing Crohn's Disease

NCT03077412 ·Status: COMPLETED ·Phase: PHASE2

A Study To Investigate The Safety And Efficacy Properties Of PF-00547659 In Patients With Active Ulcerative Colitis

NCT00928681 ·Status: COMPLETED ·Phase: PHASE1

A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis

NCT03844932 ·Status: TERMINATED ·Phase: PHASE2

A Study of MK-6194 (PT101) in Participants With Active Ulcerative Colitis (UC) (MK-6194-002)

NCT04924114 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis

NCT06867094 ·Status: RECRUITING ·Phase: PHASE2

This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcerative Colitis Using Real World Data.

NCT05082428 ·Status: COMPLETED

Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population

NCT07177209 ·Status: ACTIVE_NOT_RECRUITING

Study of OST-122 in Patients With Moderate to Severe Ulcerative Colitis

NCT04353791 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

NCT02914561 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis

NCT01434576 ·Status: WITHDRAWN ·Phase: PHASE1

Fecal Microbiota Transplantation in Patients With Ulcerative Colitis

NCT01961492 ·Status: WITHDRAWN ·Phase: NA

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

NCT01659138 ·Status: TERMINATED ·Phase: PHASE2

Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis

NCT01829321 ·Status: COMPLETED ·Phase: PHASE2

Golimumab in Ulcerative Colitis (UC) Patients With Loss of Response (LOR) Followed by Dose Optimization

NCT03182166 ·Status: COMPLETED ·Phase: PHASE2

Clinical Study to Evaluate the Possible Efficacy and Safety of Febuxostat in Patients With Ulcerative Colitis Treated With Mesalamine

NCT06525974 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis

NCT04424303 ·Status: COMPLETED

Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis

NCT05907330 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Dose-finding Study of SAR443122 in Adult Participants With Ulcerative Colitis

NCT05588843 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

NCT06979336 ·Status: RECRUITING ·Phase: PHASE2

Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study

NCT03772145 ·Status: TERMINATED

An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)

NCT05084261 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis

NCT06588855 ·Status: RECRUITING ·Phase: PHASE3

European Safety Registry in Ulcerative Colitis (P04808)

NCT00705484 ·Status: COMPLETED

A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis

NCT01620255 ·Status: COMPLETED ·Phase: PHASE2